Acumen research and consulting estimates that the global proteomics market is anticipated to reach market size of around US$ 75,000 Mn by 2027 and is anticipated to grow at a CAGR of around 14% in terms of revenue during the forecast period 2020 – 2027.
Proteomics is a study of the protein structure and function used in drug development, diagnosis and disease management. A proteome is never constant as it differs over time from cell to cell. Proteomics is employed to assess protein production rates, protein interaction with each other, metabolic pathways presence of proteins, and protein modification. Structural proteomics are used to detect protein complex structures while functional proteomics are used to demonstrate protein functions in protein-protein interactions.
Growing demand for personalized drugs, increasing research and development investment by leading players on the market, various advancements in technology, increased awareness of multiple proteomic applications, increased cases of genetic diseases, proteomics capacity to cross the gap between cellular try to combat and genome expression and the rapid introduction of new technologies are the factors that are flourishing the global market. Government efforts to track research and development operation will provide market players on the global proteomics market with new prospects in the near future. The high cost of equipment, the lack of expert professionals and a lack of awareness of proteomics and their application in developing regions can, however, restrict the global proteomics market.
Drug Discovery is expected to hold a Significant Market Share in the Application Type
Among the most promising development in the study of human genes and proteins has been the discovery of possible new drugs for the treatment of disease. It relies on genome and proteome data to classify proteins linked to a disorder, and can then be used as a computer software guide for new drugs. In order for drug applicants to describe the results on cells and model organisms, preclinical stages of drug development require a multitude for genetic and biochemical evaluation. Almost every large drug company now has biotech or academic partners oriented towards proteomics, or started their own division for proteomics. Specific applications in the drugs industry include the detection, targeting and testing recognition and processes of product activity or toxicity studies on the effectiveness and the toxicity of the biomarkers from easily available biological fluids.
The market research study on “Proteomics Market (By Component: Instruments (Microarray, Spectrometry, X-ray Crystallography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation Reagents), Reagents (Microarray, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Immunoassay, Protein Fractionation Reagents), Services; By Application: Drug Discovery, Disease Diagnosis, Others) - Global Industry, Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers detailed insights on the global proteomics market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report provides insights on global proteomics market are component, application, and major geographic regions. The proteomics market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
North America accounts to hold large market share of global proteomics market and is expected to grow during forecast period due to increasing investment by academic institutions in genomics and proteomics research, large investment for research and development, government initiatives, increasing implementation of tailored medicine, and the presence of healthcare facilities are the major driving factors for the market in North America. Dueto the presence of professional scientists, strong R&D spending by leading companies, an growing geriatric population, an rising incidence of chronic diseases, and a favorable reimbursement scenario Europe will become in future the second largest proteomics market worldwide. Due to increased prevalence of chronic diseases, increased investments in proteomics, increased research and development of proteomic applications and also the wide penetration of proteomics in disease diagnosis and therapy the Asia Pacific proteomics market will be rapidly rising during the forecast period.
Major players included in this report are Danaher Corporation, Agilent Technologies Inc., LI-COR, Inc., PerkinElmer, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, General Electric (GE), Waters Corporation, and others. The global market in proteomics is moderately focused. The market is in the initial phase of expansion, and by the end of the forecast period demand is expected to decrease. The study will help consumers find potential business opportunities and implement alternative growth plans by providing an outline of the competitive environment and insights on the products offered by the firms.
The global proteomics market is segmented as below:
Proteomics Market By Component
Proteomics Market By Application
Proteomics Market By Geography
Middle East & Africa
Proteomics is a study of the protein structure and function used in drug development, diagnosis and disease management.
Structural proteomics are used to detect protein complex structures while functional proteomics are used to demonstrate protein functions in protein-protein interactions.
According to the Acumen Research and Consulting, The global proteomics market value is expected to reach around US$ 75,000 million by 2027.
The proteomics market is anticipated to grow around 14% CAGR amid the forecast period 2020-2027.
North America accounts to hold large market share of global proteomics market.
The key players operating in proteomics market such as Danaher Corporation, Agilent Technologies Inc., LI-COR, Inc., PerkinElmer, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, General Electric (GE), Waters Corporation, and others.
The presence of healthcare facilities are the major driving factors for the market in North America.